European shares slipped into the red on Thursday as Ukrainian and separatist forces in the country's east traded accusations of having broken ceasefire agreements along the demarcation line.
The market spotlight at the end of the week will be UK retail sales figures for the month of January.
London stocks closed in negative territory on Thursday, as concerns over relations between Russia and Ukraine grew again.
GlaxoSmithKline disclosed a number of executive awards on Thursday, with two of its directors making large sales to cover their tax bills.
West Africa and India-focussed gold exploration and development company Panthera Resources announced on Thursday that five metre composite assays had now been received and compiled from all of the second stage aircore drilling at the Bassala Project in Mali.
Barclays initiated coverage of value-added IT products reseller and services firm Bytes Technology at 'overweight' on Thursday with a 640. 0p price target.
London’s FTSE 250 was down 1. 2% at 21,573. 36 in afternoon trade on Thursday.
Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1. 5m in a trading update on Thursday, in line with market expectations.
CIP Merchant Capital has sold 40,000 shares in Alkemy, it announced on Thursday, for €0. 8m net of commissions and expenses.
Online comparison website Moneysupermarket. com posted a decline in full-year profit and revenue on Thursday following a strong performance from its money division but weakness in home services and insurance.
Wall Street stocks were firmly in the red early on Thursday as market participants monitored developments in the Russia-Ukraine conflict and digested a number of data points at the open.
Clinical diagnostics company Novacyt announced on Thursday that its ‘PROmate’ Covid-19 2G Real-Time PCR test had been approved in the UK, under the UK Health Security Agency's coronavirus test device approvals (CTDA) regulations.
SkinBioTherapeutics updated the market on Thursday on the commercialisation of its food supplement product ‘AxisBiotix-Ps’, designed for the symptoms of psoriasis.
London’s FTSE 100 was 1. 2% lower at 7,510. 34 in afternoon trade on Thursday.
JD Sports announced a delay to the release of its full-year results but said the numbers were set to be "slightly ahead" of expectations following a continued positive performance in January.
Molecular diagnostic company Yourgene has received confirmation from the UK Health Security Agency that the ‘Clarigene’ SARS-CoV-2 test has been approved under the requirements set out in the Coronavirus Test Device Approvals regulations, it announced on Thursday.
The number of Americans filing first-time unemployment claims registered their sharpest increase in four weeks, well ahead of market expectations for a print of 219,000.
US retail giant Walmart lifted its dividend on Thursday as it said it swung to a profit in the fourth quarter.
Factory activity in the US mid-Atlantic region slowed a little in February, the results of a closely-followed survey revealed.
Analysts at Berenberg raised their target price on mining outfit Tharisa from 200. 0p to 220. 0p on Thursday, stating the group's recent acquisition of its Black Economic Empowerment partners' 26% stake in Tharisa Minerals would be accretive to its net asset value.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.
The value of investments can fall and you may get back less than you invested.